blood pressure, energy production, active transmembrane transport for other ions, synthesis of nuclear materials and bone development. 3 Admission hypomagnesemia (Sr.Mg <1.5 mg/dL) has been linked with an increased risk of septic shock. Mg has been known to play an important role in the regulation of immune systems and inflammatory response and the release of nitric oxide. 2 Hypermagnesemia on the other hand can cause serious deleterious effects. Mg can block the synaptic transmission of nerve impulses and causes the initial loss of deep tendon reflexes, flaccid paralysis and apnea. It can also cause hypotension, bradycardia, prolonged QRS duration and complete heart block. 4 Studies with magnesium (Mg) and Magnesium Sulphate (MgSO4) have shown a peripheral (predominantly arteriolar) vasodilator effect with preserved cardiac function, within a large safety margin, not only indirectly by an endothelium-dependent release of Nitric Oxide (NO) but also directly via its ability to induce endothelium-independent vasodilation by a direct action on vascular smooth muscle as a calcium competitor. In addition to vasodilatory effects, infusion of MgSO4 is also associated with other potential pro-microcirculatory effects, such as an increase in red blood cell deformability, reduction of platelet aggregation, antiinflammatory effects and maintenance of endothelial integrity. 5 In a study by Rubeiz et al, they found that the APACHE II scores were similar in ICU patients with hypomagnesemia versus patients without hypomagnesemia, however, the mortality was significantly higher in the hypomagnesemia group. 6, 7 Microcirculatory alterations have a critical role in sepsis and persist despite correction of systemic hemodynamic parameters. Mg is involved in both endotheliumdependent and non-endothelium-dependent vasodilatory pathways. As cell membrane calcium channels are Mg dependent and Mg seems to be a factor regulating sepsisassociated calcium entry, Mg is strongly correlated with calcium ion entry in septic shock. 8 The purpose of this study was to evaluate admission serum magnesium levels in patients with septic shock (as per the Sepsis-3 definition) and to determine its correlation to the outcomes. 9 Objective of the study was to assess Serum Magnesium levels in patients with septic shock admitted to intensive care unit and follow such patients for progression of organ failures with Sequential Organ Failure Assessment (SOFA) score. 10 To compare admission APACHE II score with admission Serum Magnesium levels in patient with Septic shock to correlate admission Serum Magnesium levels in patient with septic shock with ICU and Hospital mortality. To correlate admission Serum Magnesium levels in patients with septic shock with length of stay in ICU, Hospital length of Stay, Dialysis free days, Vasopressor free days and Ventilator free days.
METHODS
The present study was conducted at the attached teaching hospital after approval of the institutional Ethics Committee.
Study design was a prospective observational study. All patients admitted to intensive care unit were screened for septic shock. 9
Inclusion criteria
• All patients admitted to intensive care unit with signs of septic shock as per the Sepsis-3 definition.
Exclusion criteria
• Written informed consent was obtained from all patients prior to inclusion into the study. Date and address were confirmed from all patients. Patients with suspected infection were identified at the bedside with qSOFA, i.e. alteration in mental status, systolic blood pressure ≤100 mm Hg, or respiratory rate ≥22/min. 11 Patients with septic shock were identified with a clinical construct of sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg and having a serum lactate level >2 mmol/L (18 mg/dL) despite adequate volume resuscitation. Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality.
Admission serum magnesium levels was measured for all patients included. Normal reference range for Serum Magnesium is 1.6 to 2.5 mg/dL. Hypomagnesemia is defined as serum magnesium <1.6 mg/dL, Hypermagnesemia is defined as serum magnesium >2.5 mg/dL. The Randox Xylidil Blue Colorimetric method was used for estimation of serum Magnesium levels in laboratory. APACHE II scores were calculated at the end of 24 hours after admission.
Routine standard of care treatment like resuscitation, cultures and antibiotics was provided to all patients. The patients were monitored for organ dysfunctions based on daily SOFA scores, ventilator free days, vasopressors free days, dialysis free days, length of intensive care unit stay, length of hospital stay.
Anticipated Risk Factors: No risks involved.

Data analysis
The data was statistically analyzed using Statistical Package for Social Sciences (IBM SPSS version 25) for MS Windows. The data on qualitative characteristics was presented in percentages. The data on quantitative characteristics was presented as Mean±Standard deviation (SD). On the basis of laboratory results the patients were divided into 3 groups Hypomagnesaemia, Normomagnesemia and Hypermagnesemia on admission. The statistical significance of difference in qualitative characteristics was tested using Chi-Square test. The statistical significance of inter-group difference of mean of quantitative variables was tested using unpaired 't' test. The statistical significance of intra-group difference of mean of quantitative variables was tested using Analysis of Variance (ANOVA), p-values less than 0.05 was considered to be statistically significant.
RESULTS
The study included 50 patients with the youngest patient being 18 years and the oldest 72 years. Baseline characteristics of study population are shown in table 1. On admission, 18% (09/50) patients had hypomagnesemia, 62% (31/50) had hypermagnesemia and 20% (10/20) had normal serum magnesium levels. The lowest serum magnesium value recorded was 0.9mg/dL while the highest value was 3.53 mg/dL. There was no statistically significant variation of age, gender amongst the groups. There was no statistically significant difference in admission magnesium levels among both diabetic and non-diabetic patients. 
DISCUSSION
The aim of this study was to evaluate the admission serum magnesium levels in patients with septic shock and its correlation with outcome. In this study author did not find any statistically significant relation between distribution of age and gender across the study population.
This distribution of patients across these 3 groups was as follows: Hypomagnesemia 9/50(18%) Normomagnesemia in 31/50(62%) Hypermagnesemia in 10/20(20%) which was similar to study findings done by Soliman et al. 12 Author found a higher incidence of diabetes among the hypermagnesemic group as compared to the hypomagnesemic group. This finding is similar to those of Thongprayoon C et al. 2 Although the relationship between magnesium and diabetes has been studied and also found to be significant by other studies whether the relationship is causal is not clear.
Many studies have demonstrated a statistically significant relation between the incidence of hypomagnesemia and the occurrence of sepsis Limaye et al, 38% patients with hypomagnesemia were septic, Kumar et al, 34% patients with hypomagnesemia were septic. 13, 14 In our study author looked at only septic shock patients and their correlation with magnesium and SOFA score. Authors did not find any literature on patients with septic shock where the causal relationship of magnesium with SOFA score has been studied.
The finding of this study of a longer duration of mechanical ventilation in the hypomagnesemic patients was similar to the studies done by Safavi et al, Limaye et al, and Gupta et al. 15, 13, 16 The findings of this study were that the vasopressor free days were higher in hypomagnesemic patients than in hypermagnesemic patients. This suggests that vasopressors were required for a longer period in hypermagnesemic patients. This finding was similar to the observations of Celi et al. 17 Author did not come across any studies in a septic shock population correlating serum magnesium values with vasopressor free days.
In this study the mean baseline creatinine was also higher in the hypermagnesemic group (mean creatinine value 1.56 mg/dL) suggesting that there may be an underlying element of subclinical AKI in this subset. Authors did not find any studies looking at dialysis free days in septic shock patients with dysmagnesemia.
Although in this study the mean duration of ICU stay was higher in hypomagnesemia group than in hypermagnesemia group, this difference was not statistically significant. The studies done by Chernow et al, 1989 Limaye et al, 2011 they did not find any statistically significant correlation between length of ICU stay and magnesium levels. 18, 13 In this study This difference between hypomagnesemia and hypermagnesemia groups was not statistically significant. Of the 32 that survived, 11 patients (34%) had abnormal magnesium values. These results were not statistically significant.
Jiang Pan et al, 2017 performed a systematic review and meta-analysis to evaluate the association of serum magnesium level with prognosis of critically ill patients upon admission to the ICU. 10, 19 studies comprising 1,122 cases and 630 controls were finally selected for analysis. The patients with hypomagnesemia had higher mortality rate (risk ratio [RR] 1.76; 95% Confidence Interval [CI] 1.54-2.00; p<0.00001).
In this study of 50 patients with septic shock hypomagnesemia was prevalent in 18%, normomagnesemia in 62% and hypermagnesemia in 20%.
Author found the following correlations to be statistically significant • SOFA score in hypomagnesemic patients admitted with septic shock with those of normomagnesemic and hypermagnesemic patients was statistically significant (p value 0.027 and 0.018 respectively). • Vasopressor free days between normomagnesemic and hypermagnesemic patients (p value 0.022). • Dialysis free days between normomagnesemic and hypermagnesemic patients (p value 0.031).
There was no statistically significant correlation between the groups with respect to APACHE II score, need for mechanical ventilation and dialysis, ventilator free days, length of ICU stay, hospital length of stay and mortality.
